AMA submission to the government review of medicines and medical devices regulation

The AMA lodged a submission in response to a government review of medicines and medical devices regulation. The AMA’s submission focused on issues related to adverse event reporting, clinical device registries, medicines scheduling, currency of medicine product information documentation, and advertising, consistent with existing AMA policy.

The AMA’s other submissions to the review are provided in the following links: